Outcomes of Neoadjuvant Chemoradiation With and Without Systemic Chemotherapy in Resectable and Borderline Resectable Pancreatic Adenocarcinoma

Introduction: Neoadjuvant therapy is increasingly being used for localized pancreatic adenocarcinoma. While there is evidence supporting neoadjuvant systemic chemotherapy as well as chemoradiation, more evidence is needed to determine whether systemic chemotherapy with chemoradiation offers benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinh, Katherine V., Fischer, Dawn A., Gardner, Timothy B., Smith, Kerrington D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525017/
https://www.ncbi.nlm.nih.gov/pubmed/33042792
http://dx.doi.org/10.3389/fonc.2020.01461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525017/
https://www.ncbi.nlm.nih.gov/pubmed/33042792
http://dx.doi.org/10.3389/fonc.2020.01461

Ejemplares similares